Search

Your search keyword '"Balduzzi, Sara"' showing total 260 results

Search Constraints

Start Over You searched for: Author "Balduzzi, Sara" Remove constraint Author: "Balduzzi, Sara"
260 results on '"Balduzzi, Sara"'

Search Results

1. Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [18F]FDG PET/CT: a systematic review and individual patient data meta-analysis

2. Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

3. Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

8. PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial

9. Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer

12. Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy.

14. Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective Study

15. Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines

17. Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial

18. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients

19. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis

20. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients

21. Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer

23. Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

24. Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer.

26. Abstract P2-11-12: Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts

27. Radiotherapy, atezolizumab, and bevacizumab in rectal cancers with the aim of organ preservation: The TARZAN study.

28. PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer:the GELATO trial

29. netmeta: An R Package for Network Meta-Analysis Using Frequentist Methods

30. Pediatric Bilateral Vocal Cord Immobility: New Treatment With Preservation of Voice.

33. Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinsons Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial

34. Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial

37. Neoadjuvant atezolizumab plus docetaxel/oxaliplatin/capecitabine in non-metastatic gastric and gastroesophageal junction adenocarcinoma: The PANDA trial.

39. Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients:A systematic review and meta-analysis

40. Additional file 1 of Evaluating agreement between bodies of evidence from randomized controlled trials and cohort studies in medical research: a meta-epidemiological study

44. Topical treatment for hemorrhoids

46. Pharmacologic thromboprophylaxis in adult patients undergoing neurosurgical interventions for preventing venous thromboembolism

47. Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

48. Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

49. MOESM1 of Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

Catalog

Books, media, physical & digital resources